{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:38:01Z","timestamp":1791430681055,"version":"4.3.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This review aimed to synthesize the experiences of patients with metachromatic leukodystrophy, adrenoleukodystrophy, or Krabbe disease and the experiences of their families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Leukodystrophies are metabolic diseases caused by genetic mutations. There are multiple forms of the disease, varying in age of onset and symptoms. The progression of leukodystrophies worsens central nervous system symptoms and significantly affects the lives of patients and their families.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Inclusion criteria:<\/jats:title>\n                    <jats:p>Qualitative studies on the experiences of patients with leukodystrophies and their family members were included. These experiences included treatments such as enzyme replacement therapy and hematopoietic stem cell transplantation; effects of tracheostomy and gastrostomy; burdens on the family, coordinating care within the health care system, and family planning due to genetic disorders. This review considered studies in any setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>MEDLINE (Ovid), CINAHL Plus (EBSCOhost), APA PsycINFO (EBSCOhost), Scopus, and MedNar databases were searched on November 18, 2022. Study selection, critical appraisal, data extraction, and data synthesis were conducted in accordance with the JBI methodology for systematic reviews of qualitative evidence, and synthesized findings were evaluated according to the ConQual approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eleven studies were eligible for synthesis, and 45 findings were extracted corresponding with participants\u2019 voices. Of these findings, 40 were unequivocal and 5 were credible. The diseases in the included studies were metachromatic leukodystrophy and adrenoleukodystrophy; no studies were identified for patients with Krabbe disease and their families. These findings were grouped into 11 categories and integrated into 3 synthesized findings, including i) providing care by family members and health care providers as physical symptoms progress, which relates to the effects of the characteristics of progressive leukodystrophies; ii) building medical teamwork to provide appropriate support services, comprising categories related to the challenges experienced with the health care system for patients with leukodystrophy and their families; and iii) coordinating family functions to accept and cope with the disease, which included categories related to family psychological difficulties and role divisions within the family. According to the ConQual criteria, the second synthesized finding had a low confidence level, and the first and third synthesized findings had a very low confidence level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The synthesized findings of this review provide evidence on the experiences of patients with metachromatic leukodystrophy or adrenoleukodystrophy and their families. These findings indicate that there are challenges in managing a patient\u2019s physical condition and coordinating the health care system and family functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review registration:<\/jats:title>\n                    <jats:p>PROSPERO CRD42022318805<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Supplemental digital content:<\/jats:title>\n                    <jats:p>A Japanese-language version of the abstract of this review is available [http:\/\/links.lww.com\/SRX\/A49].<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-23-00303","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:06:51Z","timestamp":1711516011000},"page":"1262-1302","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Experiences of patients with metachromatic leukodystrophy, adrenoleukodystrophy, or Krabbe disease and the experiences of their family members: a qualitative systematic review"],"prefix":"10.11124","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-4955","authenticated-orcid":false,"given":"Yuta","family":"Koto","sequence":"first","affiliation":[{"name":"Faculty of Nursing, Graduate School of Nursing, Kansai Medical University, Osaka, Japan"},{"name":"The Japan Centre for Evidence Based Practice: A JBI Centre of Excellence, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Ueki","sequence":"additional","affiliation":[{"name":"The Japan Centre for Evidence Based Practice: A JBI Centre of Excellence, Osaka, Japan"},{"name":"Faculty of Medical Sciences, Department of Health Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyae","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"The Japan Centre for Evidence Based Practice: A JBI Centre of Excellence, Osaka, Japan"},{"name":"Department of Evidence-Based Clinical Nursing, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Sakai","sequence":"additional","affiliation":[{"name":"Child Healthcare and Genetic Science Laboratory, Division of Health Science, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7]]},"reference":[{"issue":"11","key":"R1-20250613","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jnr.23792","article-title":"Gene therapy for metachromatic leukodystrophy","volume":"94","author":"Rosenberg","year":"2016","journal-title":"J Neurosci Res"},{"key":"R2-20250613","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"R3-20250613","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jnr.23891","article-title":"Clinical management of Krabbe disease","volume":"94","author":"Escolar","year":"2016","journal-title":"J Neurosci Res"},{"issue":"3","key":"R4-20250613","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymgme.2021.05.004","article-title":"Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: a nationwide survey in Japan","volume":"133","author":"Koto","year":"2021","journal-title":"Mol Genet Metab"},{"issue":"2","key":"R5-20250613","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"R6-20250613","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1212\/WNL.0000000000011047","article-title":"Association of age at onset and first symptoms with disease progression in patients with metachromatic leukodystrophy","volume":"96","author":"Kehrer","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"R7-20250613","doi-asserted-by":"crossref","first-page":"e185031","DOI":"10.1001\/jamanetworkopen.2018.5031","article-title":"Association of diagnosis of leukodystrophy with race and ethnicity among pediatric and adolescent patients","volume":"1","author":"Bonkowsky","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"17","key":"R8-20250613","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"R9-20250613","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/gim.2015.211","article-title":"Newborn screening for Krabbe disease in New York State: the first eight years\u2019 experience","volume":"18","author":"Orsini","year":"2016","journal-title":"Genet Med"},{"issue":"1","key":"R10-20250613","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"R11-20250613","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"R12-20250613","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"R13-20250613","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1177\/0883073816656401","article-title":"Metachromatic leukodystrophy: an assessment of disease burden","volume":"31","author":"Eichler","year":"2016","journal-title":"J Child Neurol"},{"issue":"1","key":"R14-20250613","first-page":"47","article-title":"Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy","volume":"47","author":"Langan","year":"2019","journal-title":"JIMD Rep"},{"issue":"1","key":"R15-20250613","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13023-021-01828-y","article-title":"The impact of severe rare chronic neurological disease in childhood on the quality of life of families \u2013 a study on MLD and PCH2","volume":"16","author":"Ammann-Schnell","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"R16-20250613","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijns5040042","article-title":"Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California","volume":"5","author":"Schwan","year":"2019","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"R17-20250613","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1359105312467388","article-title":"The lived experience of Taiwanese mothers of a child diagnosed with adrenoleukodystrophy","volume":"19","author":"Lee","year":"2014","journal-title":"J Health Psychol"},{"issue":"1","key":"R18-20250613","first-page":"27","article-title":"The long-term care experiences and care needs of parents caring for children with adrenoleukodystrophy","volume":"66","author":"Feng","year":"2019","journal-title":"Hu Li Za Zhi"},{"issue":"1","key":"R19-20250613","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13023-021-01943-w","article-title":"Navigating the U.S. health insurance landscape for children with rare diseases: a qualitative study of parents\u2019 experiences","volume":"16","author":"Pasquini","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"R20-20250613","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ejhg.2008.104","article-title":"Health first, genetics second: exploring families\u2019 experiences of communicating genetic information","volume":"16","author":"Forrest","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"R22-20250613","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2288-14-108","article-title":"Establishing confidence in the output of qualitative research synthesis: the ConQual approach","volume":"14","author":"Munn","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"R23-20250613","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.11124\/JBIES-22-00154","article-title":"Experiences of patients and their family members with metachromatic leukodystrophy, adrenoleukodystrophy, and Krabbe disease: a qualitative systematic review protocol","volume":"21","author":"Koto","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"1","key":"R24-20250613","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/XEB.0000000000000152","article-title":"The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI)","volume":"17","author":"Munn","year":"2019","journal-title":"Int J Evid Based Healthc"},{"key":"R25-20250613","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"R26-20250613","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","article-title":"Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation","volume":"13","author":"Lockwood","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"4","key":"R27-20250613","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/08830738211065317","article-title":"Experience of parents of children with genetically determined leukoencephalopathies regarding the adapted health care services during the COVID-19 pandemic","volume":"37","author":"Amir Yazdani","year":"2022","journal-title":"J Child Neurol"},{"issue":"1","key":"R28-20250613","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-019-1060-2","article-title":"Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers","volume":"14","author":"Harrington","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"R29-20250613","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.arcped.2015.06.009","article-title":"Psychological distress of children with progressive diseases and multiple disabilities: a crossed analysis","volume":"22","author":"Perifano","year":"2015","journal-title":"Arch Pediatr"},{"issue":"1","key":"R30-20250613","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41687-018-0041-x","article-title":"Development of the impact of juvenile metachromatic leukodystrophy on physical activities scale","volume":"2","author":"Brown","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"R31-20250613","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-022-02518-z","article-title":"Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy","volume":"17","author":"Eichler","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"R32-20250613","first-page":"156","article-title":"Ways of weaving networks for the care by the family that is experiencing the chronic condition by adrenoleukodystrophy","volume":"11","author":"Nepomuceno","year":"2012","journal-title":"Cienc Cuid Saude"},{"issue":"1","key":"R33-20250613","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-022-02550-z","article-title":"The importance of early diagnosis and views on newborn screening in metachromatic leukodystrophy: results of a Caregiver Survey in the UK and Republic of Ireland","volume":"17","author":"Morton","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R34-20250613","first-page":"e03398","article-title":"Men\u2019s position in family care on situations of chronic illness","volume":"52","author":"Santos","year":"2018","journal-title":"Rev Esc Enferm USP"},{"issue":"6","key":"R35-20250613","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.11124\/JBIES-21-00074","article-title":"Experiences of patients with lysosomal storage disorders who are receiving enzyme-replacement therapy and the experiences of their family members: a qualitative systematic review","volume":"20","author":"Koto","year":"2022","journal-title":"JBI Evid Synth"},{"issue":"6","key":"R36-20250613","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/mgg3.315","article-title":"Living with a rare disorder: a systematic review of the qualitative literature","volume":"5","author":"von der Lippe","year":"2017","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"R37-20250613","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.beem.2014.10.001","article-title":"Metachromatic leukodystrophy: disease spectrum and approaches for treatment","volume":"29","author":"van Rappard","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10322","key":"R38-20250613","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"R39-20250613","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13023-022-02189-w","article-title":"Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for metachromatic leukodystrophy: the European Metachromatic Leukodystrophy initiative (MLDi)","volume":"17","author":"Schoenmakers","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"R40-20250613","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/08830738231176672","article-title":"The experience of parents of children with genetically determined leukoencephalopathies with the health care system: a Qualitative Study","volume":"38","author":"Yazdani","year":"2023","journal-title":"J Child Neurol"},{"issue":"10","key":"R41-20250613","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"van der Knaap","year":"2019","journal-title":"Lancet Neurol"},{"issue":"3","key":"R42-20250613","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jimd.12356","article-title":"MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines","volume":"44","author":"Mallack","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"R43-20250613","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-022-02501-8","article-title":"An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy","volume":"17","author":"Sevin","year":"2022","journal-title":"Orphanet J Rare Dis"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-23-00303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:34:05Z","timestamp":1786451645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.11124\/JBIES-23-00303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.11124\/jbies-23-00303","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]}}}